In 2020, he systematically elucidated how metformin combined with AE improves glucose metabolism in T2DM patients by regulating molecular mechanisms such as insulin receptors and glucose transporter 4 (GLUT4) translocation, providing high-level evidence-based support for clinical practice. The gene discussed is INSR; the disease is type 2 diabetes mellitus.